PERSPECTIVE THERAPEUTICS, INC. (CATX) Current Ratio
- Current ratio · latest quarter: Value 6.61×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 6.61× | Current assets / current liabilities. $241.52M ÷ $36.54M ≈ 6.61× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 241.52M USD | Assets, Current |
| Current obligations | 36.54M USD | Liabilities, Current |
| Cash and equivalents | 48.49M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 269.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | (m) | |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $241.52M | $36.54M | $48.49M | (m) | $269.00K | (m) | (m) | (m) | 6.61× |
| 2026-03-31 | $275.35M | $31.49M | $53.97M | (m) | $58.00K | (m) | (m) | (m) | 8.75× |
| 2025-12-31 | $148.39M | $28.68M | $30.63M | (m) | $6.00K | (m) | (m) | (m) | 5.17× |
| 2025-09-30 | $178.50M | $20.62M | $26.76M | (m) | $179.00K | (m) | (m) | (m) | 8.66× |
| 2025-06-30 | $195.96M | $12.99M | $28.85M | (m) | $225.00K | (m) | (m) | (m) | 15.09× |
| 2025-03-31 | $215.74M | $12.68M | $44.41M | (m) | $78.00K | (m) | (m) | (m) | 17.02× |
| 2024-12-31 | $231.16M | $18.23M | $61.58M | (m) | $116.00K | (m) | (m) | (m) | 12.68× |
| 2024-09-30 | $270.17M | $28.14M | $226.44M | (m) | $217.00K | (m) | (m) | (m) | 9.60× |
| 2024-06-30 | $294.24M | $10.61M | $252.00M | (m) | $142.00K | (m) | (m) | (m) | 27.73× |
| 2024-03-31 | $188.20M | $14.50M | $142.12M | (m) | $999.00K | (m) | (m) | (m) | 12.98× |
| 2023-12-31 | $16.84M | $15.66M | $9.24M | (m) | $1.17M | (m) | (m) | (m) | 1.07× |
| 2023-09-30 | $21.69M | $8.12M | $17.98M | (m) | $1.73M | $1.01M | (m) | (m) | 2.67× |
| 2023-06-30 | $31.95M | $8.59M | $28.32M | (m) | $1.11M | $1.09M | (m) | (m) | 3.72× |
| 2023-03-31 | $40.27M | $7.19M | $36.45M | (m) | (m) | $1.41M | (m) | (m) | 5.60× |
| 2022-12-31 | $53.22M | $3.12M | $20.99M | (m) | $1.36M | (m) | (m) | (m) | 17.07× |
| 2022-09-30 | $57.54M | $4.00M | $18.99M | (m) | (m) | $1.55M | (m) | (m) | 14.38× |
| 2022-06-30 | $59.33M | $2.27M | $55.89M | (m) | $1.61M | $1.40M | (m) | (m) | 26.18× |
| 2022-03-31 | $62.76M | $1.96M | $58.90M | (m) | (m) | $1.16M | (m) | (m) | 32.08× |
| 2021-12-31 | $63.60M | $1.84M | $60.35M | (m) | (m) | $1.07M | (m) | (m) | 34.47× |
| 2021-09-30 | $64.96M | $1.80M | $61.69M | (m) | (m) | $1.06M | (m) | (m) | 36.11× |
| 2021-06-30 | $67.30M | $1.80M | $63.83M | (m) | $2.01M | $980.00K | (m) | (m) | 37.37× |
| 2021-03-31 | $68.07M | $1.92M | $64.84M | (m) | (m) | $731.00K | (m) | (m) | 35.53× |
| 2020-12-31 | $12.29M | $1.33M | $9.59M | (m) | (m) | $665.00K | (m) | (m) | 9.21× |
| 2020-09-30 | $4.75M | $1.52M | $1.94M | (m) | (m) | $641.00K | (m) | (m) | 3.12× |
| 2020-06-30 | $5.51M | $1.57M | $2.39M | (m) | (m) | $645.00K | (m) | (m) | 3.50× |
| 2020-03-31 | $5.72M | $1.74M | $2.40M | (m) | (m) | $580.00K | (m) | (m) | 3.28× |
| 2019-12-31 | $5.63M | $1.34M | $3.18M | (m) | (m) | $545.00K | (m) | (m) | 4.20× |
| 2019-09-30 | $6.81M | $1.67M | $4.58M | (m) | (m) | $501.00K | (m) | (m) | 4.09× |
| 2019-06-30 | $7.32M | $1.12M | $5.33M | (m) | (m) | $530.00K | (m) | (m) | 6.53× |
| 2019-03-31 | $8.43M | $1.35M | $4.06M | (m) | (m) | $533.00K | (m) | (m) | 6.22× |
| 2018-12-31 | $9.82M | $1.64M | $3.20M | (m) | (m) | $494.00K | (m) | (m) | 5.99× |
| 2018-09-30 | $11.27M | $1.64M | $2.19M | (m) | (m) | $487.00K | (m) | (m) | 6.88× |
| 2018-06-30 | $5.45M | $1.83M | $2.60M | (m) | (m) | $494.00K | (m) | (m) | 2.97× |
| 2018-03-31 | $6.33M | $1.12M | $2.37M | (m) | (m) | $458.00K | (m) | (m) | 5.63× |
| 2017-12-31 | $7.42M | $931.00K | $2.95M | (m) | (m) | $459.00K | (m) | (m) | 7.97× |
| 2017-09-30 | $8.87M | $1.07M | $3.96M | (m) | (m) | $453.00K | (m) | (m) | 8.31× |
| 2017-06-30 | $10.29M | $1.11M | $5.93M | (m) | (m) | $323.00K | (m) | (m) | 9.30× |
| 2017-03-31 | $11.92M | $1.14M | $5.10M | (m) | (m) | $314.00K | (m) | (m) | 10.46× |
| 2016-12-31 | $13.18M | $871.00K | $6.67M | (m) | (m) | $381.00K | (m) | (m) | 15.13× |
| 2016-09-30 | $14.93M | $1.12M | $8.46M | (m) | (m) | $380.00K | (m) | (m) | 13.28× |
| 2016-06-30 | $13.63M | $1.09M | $10.14M | (m) | (m) | $334.00K | (m) | (m) | 12.46× |
| 2016-03-31 | $13.24M | $1.21M | $5.69M | (m) | (m) | $457.29K | (m) | (m) | 10.92× |
| 2015-12-31 | $14.28M | $1.08M | $678.91K | (m) | (m) | $476.75K | (m) | (m) | 13.24× |
| 2015-09-30 | $15.34M | $931.38K | $1.59M | (m) | $1.13M | $460.56K | (m) | (m) | 16.47× |
| 2015-06-30 | $16.33M | $1.09M | $5.23M | (m) | (m) | $403.95K | (m) | (m) | 14.95× |
| 2015-03-31 | $11.89M | $880.91K | $1.08M | (m) | $1.04M | $464.56K | (m) | (m) | 13.49× |
| 2014-12-31 | $12.83M | $941.89K | $1.34M | (m) | $797.38K | $411.42K | (m) | (m) | 13.62× |
| 2014-09-30 | $13.73M | $979.07K | $2.08M | (m) | $962.26K | $407.48K | (m) | (m) | 14.02× |
| 2014-06-30 | $19.21M | $1.15M | $7.68M | (m) | $913.05K | $359.74K | (m) | (m) | 16.65× |
| 2014-03-31 | $25.11M | $1.02M | $23.70M | (m) | $805.33K | $387.02K | (m) | (m) | 24.60× |
| 2013-12-31 | $5.92M | $847.28K | $4.41M | (m) | $917.22K | $426.33K | (m) | (m) | 6.99× |
| 2013-09-30 | $6.90M | $969.90K | $5.28M | (m) | $962.26K | $436.24K | (m) | (m) | 7.12× |
| 2013-06-30 | $4.44M | $792.87K | $2.90M | (m) | $923.78K | $405.57K | (m) | (m) | 5.60× |
| 2013-03-31 | $5.09M | $649.27K | $3.68M | (m) | $830.03K | $356.98K | (m) | (m) | 7.84× |
| 2012-12-31 | $5.74M | $696.81K | $4.44M | (m) | $656.17K | $402.91K | (m) | (m) | 8.23× |
| 2012-09-30 | $6.50M | $578.38K | $5.03M | (m) | $845.10K | $410.46K | (m) | (m) | 11.23× |
| 2012-06-30 | $4.14M | $648.99K | $2.67M | (m) | $865.06K | $444.35K | (m) | (m) | 6.37× |
| 2012-03-31 | $4.01M | $626.11K | $2.52M | (m) | $853.10K | $441.19K | (m) | (m) | 6.40× |
| 2011-12-31 | $5.16M | $760.87K | $3.38M | (m) | $828.86K | $806.18K | (m) | (m) | 6.78× |
| 2011-09-30 | $3.56M | $918.43K | $1.59M | (m) | $972.43K | $761.91K | (m) | (m) | 3.88× |
| 2011-06-30 | $4.22M | $774.20K | $2.11M | (m) | $792.84K | $749.85K | (m) | (m) | 5.45× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |